ARMISTICE CAPITAL, LLC - BROOKLYN IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 1 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q3 2022$274,000
-87.8%
1,109,807
-74.4%
0.01%
-87.2%
Q2 2022$2,248,000
-80.1%
4,342,561
-21.0%
0.04%
-82.1%
Q1 2022$11,275,000–5,500,000–0.22%–
 Download
Other shareholders
BROOKLYN IMMUNOTHERAPEUTICS shareholders Q4 2022
NameSharesValueWeighting ↓
AJ WEALTH STRATEGIES, LLC 36,001$00.00%
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders